A Phase IV Open Label Randomized Multicenter Comparative Study Of Celecoxib Efficacy And Safety Versus Standard Doses Of Oral Diclofenac In Acute Pain Due To Cervical Sprain Related To Motor Vehicle Accident.

Status: Discontinued

Phase of Trial: Phase IV

Latest Information Update: 04 Feb 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Celecoxib (Primary) ; Diclofenac
Indications Acute pain
Focus Therapeutic Use
Sponsors Pfizer

Most Recent Events

24 Feb 2011 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
24 Feb 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
08 Sep 2010 Planned end date changed from 1 Feb 2011 to 1 Jun 2011 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight